Financials
Financial year 2025
Worth noting
- More debts than assets in the latest financial year.
- Little cash and receivables against the short-term debts.
Revenue
€ 2.2 million
▲ 8% vs 2024
Profit
Growing€ 167,732
▲ 339% vs 2024
Debts
High€ 7.6 million
▼ 10% vs 2024
Sartorius Accessia Pharma from Herstal, company number BE0650670852, closed financial year 2025 with a result of € 167,732 after tax. For that financial year Sartorius Accessia Pharma recorded revenue of € 2.2 million and equity of € -2 million. Compared with financial year 2024, the result moved from € 38,218 to € 167,732. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on April 13, 2026.
What happened at Sartorius Accessia Pharma?
What happened at Sartorius Accessia Pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Cédric VOLANTI stepped down as director. NBB
- Franck BACKERS stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 167,732 (▲ 339% vs 2024). Source: NBB ↗
- Cédric VOLANTI became a director. NBB
- Jonas Skjødt MOLLER stepped down as director. NBB
- Jonas Skjødt MOLLER became a director. NBB
- Franck BACKERS became a director. NBB
- New establishment in Herstal. KBO
In short
From € 846,110 loss in 2021 to € 167,732 profit in 2025.
Best year ever: 2025, with € 167,732 profit.
On average € 286,200 of value added per employee in 2025.
A new publication or filing at Sartorius Accessia Pharma? We notify you, reason included.
Follow Sartorius Accessia PharmaNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
The shares are held by Sartorius Xpress Biologics SA (100%).
Directors
According to the 2025 annual accounts
since 2025 · until 2031
since 2024 · until 2025
since 2024 · until 2030
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Avenue du Parc Industriel 89
4041 Herstal
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
Details
- Company number
- 0650.670.852
- VAT number
- BE 0650.670.852
- Registered office
- Avenue du Parc Industriel 89, 4041 Herstal
- Names & denominations
- Sartorius Accessia Pharma
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 22 March 2016
- Peppol
- Active · Active since 7 Jul 2026
- Activities · NACE
Verhuur en exploitatie van eigen of geleased niet-residentieel onroerend goed, exclusief terreinen
Verhuur en lease van andere machines en werktuigen en andere materiële goederen
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Verhuur en lease van medisch en paramedisch materieel
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied